Cargando…
Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?
Multiple studies have shown that antecedent diseases are less prevalent in amyotrophic lateral sclerosis (ALS) patients than the general age-matched population, which suggests possible neuroprotection. Antecedent disease could be protective against ALS or, conversely, the asymptomatic early physiolo...
Autores principales: | Hollinger, Sabrina K., Okosun, Ike S., Mitchell, Cassie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810157/ https://www.ncbi.nlm.nih.gov/pubmed/27065942 http://dx.doi.org/10.3389/fneur.2016.00047 |
Ejemplares similares
-
Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction
por: Pfohl, Stephen R., et al.
Publicado: (2018) -
A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy
por: Bond, Leila, et al.
Publicado: (2018) -
Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice
por: Irvin, Cameron W., et al.
Publicado: (2015) -
Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
por: Lee, Albert J. B., et al.
Publicado: (2023) -
Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression
por: Jeyachandran, Amilia, et al.
Publicado: (2015)